Insider Activity · SEC Form 4
Apogee Therapeutics, Inc. (APGE) Insider Trading
Apogee Therapeutics, Inc. (Biological Products, (No Diagnostic Substances)) disclosed apogee therapeutics, inc. on Sep 3, 2026. The filing is linked below — tap through to read the source.
Buys: 0 · —
Sales: 4 · $3.41M
Recent insider transactions
| Insider | Type | Shares | Price | Value | Date | Source |
|---|---|---|---|---|---|---|
| Dambkowski CarlChief Medical Officer | SELL | 5,500 | $134.17 | $737.9K | Aug 5, 2026 | Form 4 → |
| Henderson JaneChief Financial Officer | SELL | 15,000 | — | — | Jul 24, 2026 | Form 4 → |
| Dambkowski CarlChief Medical Officer | SELL | 8,000 | — | — | Jul 14, 2026 | Form 4 → |
| HENDERSON MICHAEL THOMASChief Executive Officer | SELL | 20,000 | $133.63 | $2.67M | Jul 10, 2026 | Form 4 → |
Recent SEC filings
| Filing | Date | Source |
|---|---|---|
| 8-KApogee Therapeutics, Inc. | Sep 3, 2026 | Filing → |
| 8-KApogee Therapeutics, Inc. | Aug 10, 2026 | Filing → |
| 8-KApogee Therapeutics, Inc. | Jun 22, 2026 | Filing → |
| 8-KApogee Therapeutics, Inc. | Jun 22, 2026 | Filing → |
| 8-KApogee Therapeutics, Inc. | Jun 12, 2026 | Filing → |
| 8-KMaterial Agreement Signed + Regulation FD Disclosure | May 27, 2026 | Filing → |
| 8-KRegulation FD Disclosure + Other Material Events | May 27, 2026 | Filing → |
| 8-KApogee Therapeutics, Inc. | May 27, 2026 | Filing → |
| 8-KApogee Therapeutics, Inc. | May 27, 2026 | Filing → |
| 8-KEarnings Release | May 11, 2026 | Filing → |